M. Schlumberger
M. Schlumberger
Department of Nuclear Medicine and Endocrine Oncology, Institute Gustave-Roussy and University Paris Sud, Villejuif, France
Search for other papers by M. Schlumberger in
Google Scholar
PubMed
Search for other papers by M. Schlumberger in
Google Scholar
PubMed
L. Bastholt
L. Bastholt
Department of Oncology, Odense University Hospital, Odense, Denmark
Search for other papers by L. Bastholt in
Google Scholar
PubMed
Search for other papers by L. Bastholt in
Google Scholar
PubMed
H. Dralle
H. Dralle
Department of Surgery, Martin Luther University, Halle-Wittenberg Medical Faculty, Halle/Saale, Germany
Search for other papers by H. Dralle in
Google Scholar
PubMed
Search for other papers by H. Dralle in
Google Scholar
PubMed
B. Jarzab
B. Jarzab
MSC Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
Search for other papers by B. Jarzab in
Google Scholar
PubMed
Search for other papers by B. Jarzab in
Google Scholar
PubMed
F. Pacini
F. Pacini
Department of Endocrinologia, University of Siena, Siena, Italy
Search for other papers by F. Pacini in
Google Scholar
PubMed
Search for other papers by F. Pacini in
Google Scholar
PubMed
J.W.A. Smit
J.W.A. Smit
Department of Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands
Search for other papers by J.W.A. Smit in
Google Scholar
PubMed
Search for other papers by J.W.A. Smit in
Google Scholar
PubMed
Methods of Development of Evidence-Based Guidelines The European Thyroid Association (ETA) Executive Committee launched a taskforce to produce guidelines on the treatment of metastatic medullary thyroid cancer (MTC). A chairperson was selected
Camille Buffet
Camille Buffet
Department of Thyroid Pathologies and Endocrine Tumors, AP-HP, Pitié-Salpêtrière Hospital, Groupe de Recherche Clinique n°16 Tumeurs Thyroïdiennes, Sorbonne Université, Paris, France
UMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France
Search for other papers by Camille Buffet in
Google Scholar
PubMed
UMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France
Search for other papers by Camille Buffet in
Google Scholar
PubMed
Sophie Leboulleux
Sophie Leboulleux
Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institut, Villejuif, France
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Françoise Kraeber-Bodéré
Françoise Kraeber-Bodéré
Nuclear Medicine Department, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, Nantes, France
CHU Nantes/ICO, Saint-Herblain, France
Search for other papers by Françoise Kraeber-Bodéré in
Google Scholar
PubMed
CHU Nantes/ICO, Saint-Herblain, France
Search for other papers by Françoise Kraeber-Bodéré in
Google Scholar
PubMed
Caroline Bodet-Milin
Caroline Bodet-Milin
Nuclear Medicine Department, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, Nantes, France
CHU Nantes/ICO, Saint-Herblain, France
Search for other papers by Caroline Bodet-Milin in
Google Scholar
PubMed
CHU Nantes/ICO, Saint-Herblain, France
Search for other papers by Caroline Bodet-Milin in
Google Scholar
PubMed
Laure Cabanes
Laure Cabanes
Department of Cardiology, APHP, Cochin Hospital, Paris, France
Université de Paris, Paris, France
Search for other papers by Laure Cabanes in
Google Scholar
PubMed
Université de Paris, Paris, France
Search for other papers by Laure Cabanes in
Google Scholar
PubMed
Anthony Dohan
Anthony Dohan
Radiology Department, Université de Paris, Paris, France
Department of Radiology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Anthony Dohan in
Google Scholar
PubMed
Department of Radiology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Anthony Dohan in
Google Scholar
PubMed
Pascal Leprince
Pascal Leprince
Department of Thoracic and Cardiovascular Surgery, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
Search for other papers by Pascal Leprince in
Google Scholar
PubMed
Search for other papers by Pascal Leprince in
Google Scholar
PubMed
Martin Schlumberger
Martin Schlumberger
UMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France
Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute, Villejuif, France
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute, Villejuif, France
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Olivier Huillard
Olivier Huillard
Université de Paris, Sorbonne Paris Cité, Paris, France
Department of Medical Oncology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Olivier Huillard in
Google Scholar
PubMed
Department of Medical Oncology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Olivier Huillard in
Google Scholar
PubMed
Lionel Groussin
Lionel Groussin
INSERM Unité 1016, CNRS UMR 8104, Institut Cochin, Paris, France
Université de Paris, Paris, France
Department of Endocrinology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
Université de Paris, Paris, France
Department of Endocrinology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
from medullary thyroid cancers (MTC) are uncommon. Their frequency in large autopsy series in patients with thyroid cancers is low, between 0 and 5% [ 1 - 5 ]. Given the rarity of this metastatic location, the outcome remains unclear. The average length
R. Elisei
R. Elisei
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
Search for other papers by R. Elisei in
Google Scholar
PubMed
Search for other papers by R. Elisei in
Google Scholar
PubMed
M. Alevizaki
M. Alevizaki
Endocrine Unit, Department of Medical Therapeutics, Athens University School of Medicine, Athens, Greece
Search for other papers by M. Alevizaki in
Google Scholar
PubMed
Search for other papers by M. Alevizaki in
Google Scholar
PubMed
B. Conte-Devolx
B. Conte-Devolx
Department of Endocrinology, La Timone Hospital, Aix Marseille University, Marseille, France
Search for other papers by B. Conte-Devolx in
Google Scholar
PubMed
Search for other papers by B. Conte-Devolx in
Google Scholar
PubMed
K. Frank-Raue
K. Frank-Raue
Endocrine Practice, Molecular Laboratory, Heidelberg, Germany
Search for other papers by K. Frank-Raue in
Google Scholar
PubMed
Search for other papers by K. Frank-Raue in
Google Scholar
PubMed
V. Leite
V. Leite
Department of Endocrinology, Portuguese Institute of Oncology and CEDOC, Faculty of Medical Sciences, Lisbon, Portugal
Search for other papers by V. Leite in
Google Scholar
PubMed
Search for other papers by V. Leite in
Google Scholar
PubMed
G.R. Williams
G.R. Williams
Molecular Endocrinology Group, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
Search for other papers by G.R. Williams in
Google Scholar
PubMed
Search for other papers by G.R. Williams in
Google Scholar
PubMed
Introduction Several guidelines have already been published on the diagnosis, management, and treatment of medullary thyroid cancer (MTC) [ 1 , 2 , 3 , 4 ], but there are no guidelines devoted specifically to RET genetic screening in
Carla Gambale
Carla Gambale
Department of Clinical and Experimental Medicine, Unit of Endocrinology, Pisa University Hospital, Pisa, Italy
Search for other papers by Carla Gambale in
Google Scholar
PubMed
Search for other papers by Carla Gambale in
Google Scholar
PubMed
Alessandro Prete
Alessandro Prete
Department of Clinical and Experimental Medicine, Unit of Endocrinology, Pisa University Hospital, Pisa, Italy
Search for other papers by Alessandro Prete in
Google Scholar
PubMed
Search for other papers by Alessandro Prete in
Google Scholar
PubMed
Chiara Romei
Chiara Romei
Department of Diagnostic Imaging, Unit of Radiology, Pisa University Hospital, Pisa, Italy
Search for other papers by Chiara Romei in
Google Scholar
PubMed
Search for other papers by Chiara Romei in
Google Scholar
PubMed
Alessandro Celi
Alessandro Celi
Department of Surgery, Medicine, Molecular Biology and Critical Care, Respiratory Pathophysiology Unit, Pisa University Hospital, Pisa, Italy
Search for other papers by Alessandro Celi in
Google Scholar
PubMed
Search for other papers by Alessandro Celi in
Google Scholar
PubMed
Rossella Elisei
Rossella Elisei
Department of Clinical and Experimental Medicine, Unit of Endocrinology, Pisa University Hospital, Pisa, Italy
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Antonio Matrone
Antonio Matrone
Department of Clinical and Experimental Medicine, Unit of Endocrinology, Pisa University Hospital, Pisa, Italy
Search for other papers by Antonio Matrone in
Google Scholar
PubMed
Search for other papers by Antonio Matrone in
Google Scholar
PubMed
Established facts Selpercatinib, a highly selective RET inhibitor, has demonstrated notable efficacy in advanced/progressive RET-mutant medullary thyroid cancer patients. Despite a more tolerable toxicity profile than multikinase
Laura Moss
Laura Moss
Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, United Kingdom
Search for other papers by Laura Moss in
Google Scholar
PubMed
Search for other papers by Laura Moss in
Google Scholar
PubMed
Catrin Cox
Catrin Cox
Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
Search for other papers by Catrin Cox in
Google Scholar
PubMed
Search for other papers by Catrin Cox in
Google Scholar
PubMed
Jonathan Wadsley
Jonathan Wadsley
Weston Park Cancer Centre, Sheffield, United Kingdom
Search for other papers by Jonathan Wadsley in
Google Scholar
PubMed
Search for other papers by Jonathan Wadsley in
Google Scholar
PubMed
Kate Newbold
Kate Newbold
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Mark W.J. Strachan
Mark W.J. Strachan
Western General Hospital, Edinburgh, United Kingdom
Search for other papers by Mark W.J. Strachan in
Google Scholar
PubMed
Search for other papers by Mark W.J. Strachan in
Google Scholar
PubMed
Maralyn Druce
Maralyn Druce
Barts and the London School of Medicine and Dentistry, London, United Kingdom
Search for other papers by Maralyn Druce in
Google Scholar
PubMed
Search for other papers by Maralyn Druce in
Google Scholar
PubMed
Neil Tolley
Neil Tolley
Imperial College Healthcare NHS Trust, London, United Kingdom
Search for other papers by Neil Tolley in
Google Scholar
PubMed
Search for other papers by Neil Tolley in
Google Scholar
PubMed
Kathryn Graham
Kathryn Graham
Beatson Oncology Centre, Glasgow, United Kingdom
Search for other papers by Kathryn Graham in
Google Scholar
PubMed
Search for other papers by Kathryn Graham in
Google Scholar
PubMed
Sarah Jefferies
Sarah Jefferies
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Search for other papers by Sarah Jefferies in
Google Scholar
PubMed
Search for other papers by Sarah Jefferies in
Google Scholar
PubMed
Lydia Fresco
Lydia Fresco
University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom
Search for other papers by Lydia Fresco in
Google Scholar
PubMed
Search for other papers by Lydia Fresco in
Google Scholar
PubMed
Suganya Sivabalasingham
Suganya Sivabalasingham
University College Hospital NHS Foundation Trust, London, United Kingdom
Search for other papers by Suganya Sivabalasingham in
Google Scholar
PubMed
Search for other papers by Suganya Sivabalasingham in
Google Scholar
PubMed
Alistair Balfour
Alistair Balfour
East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom
Search for other papers by Alistair Balfour in
Google Scholar
PubMed
Search for other papers by Alistair Balfour in
Google Scholar
PubMed
Chris Hurt
Chris Hurt
Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
Search for other papers by Chris Hurt in
Google Scholar
PubMed
Search for other papers by Chris Hurt in
Google Scholar
PubMed
Introduction Medullary thyroid cancer (MTC) is a rare variant of thyroid cancer with different aetiology, presentation, treatment and symptoms compared to the more common differentiated thyroid cancers (DTC). Based on Cancer Research UK (CRUK
Simona Censi
Simona Censi
Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy
Search for other papers by Simona Censi in
Google Scholar
PubMed
Search for other papers by Simona Censi in
Google Scholar
PubMed
Jacopo Manso
Jacopo Manso
Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy
Search for other papers by Jacopo Manso in
Google Scholar
PubMed
Search for other papers by Jacopo Manso in
Google Scholar
PubMed
Teresa Benvenuti
Teresa Benvenuti
Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy
Search for other papers by Teresa Benvenuti in
Google Scholar
PubMed
Search for other papers by Teresa Benvenuti in
Google Scholar
PubMed
Ilaria Piva
Ilaria Piva
Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy
Search for other papers by Ilaria Piva in
Google Scholar
PubMed
Search for other papers by Ilaria Piva in
Google Scholar
PubMed
Maurizio Iacobone
Maurizio Iacobone
Endocrine Surgery Unit, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy
Search for other papers by Maurizio Iacobone in
Google Scholar
PubMed
Search for other papers by Maurizio Iacobone in
Google Scholar
PubMed
Alberto Mondin
Alberto Mondin
Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy
Search for other papers by Alberto Mondin in
Google Scholar
PubMed
Search for other papers by Alberto Mondin in
Google Scholar
PubMed
Francesca Torresan
Francesca Torresan
Endocrine Surgery Unit, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy
Search for other papers by Francesca Torresan in
Google Scholar
PubMed
Search for other papers by Francesca Torresan in
Google Scholar
PubMed
Daniela Basso
Daniela Basso
Laboratory Medicine, Department of Medicine (DIMED), University of Padua, Padua, Italy
Search for other papers by Daniela Basso in
Google Scholar
PubMed
Search for other papers by Daniela Basso in
Google Scholar
PubMed
Gino Crivellari
Gino Crivellari
Hereditary Tumor Unit, Istituto Oncologico Veneto, IOV - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy
Search for other papers by Gino Crivellari in
Google Scholar
PubMed
Search for other papers by Gino Crivellari in
Google Scholar
PubMed
Stefania Zovato
Stefania Zovato
Hereditary Tumor Unit, Istituto Oncologico Veneto, IOV - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy
Search for other papers by Stefania Zovato in
Google Scholar
PubMed
Search for other papers by Stefania Zovato in
Google Scholar
PubMed
Caterina Mian
Caterina Mian
Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy
Search for other papers by Caterina Mian in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
Introduction Medullary thyroid cancer (MTC) originates from parafollicular C-cells and represents 2% of all thyroid malignancies and 0.4–1.4% of all thyroid nodules ( 1 ). MTC is sporadic in 75–80% of cases or manifests as a hereditary tumor
Lars Bastholt
Lars Bastholt
Department of Oncology R, Odense University Hospital, Odense, Denmark
Search for other papers by Lars Bastholt in
Google Scholar
PubMed
Search for other papers by Lars Bastholt in
Google Scholar
PubMed
Michael C. Kreissl
Michael C. Kreissl
Department of Nuclear Medicine, Augsburg Hospital, Augsburg
Department of Nuclear Medicine, University Hospital Würzburg, Würzburg
Search for other papers by Michael C. Kreissl in
Google Scholar
PubMed
Department of Nuclear Medicine, University Hospital Würzburg, Würzburg
Search for other papers by Michael C. Kreissl in
Google Scholar
PubMed
Dagmar Führer
Dagmar Führer
Department of Endocrinology and Metabolism, University Hospital Essen, Essen, Germany
Search for other papers by Dagmar Führer in
Google Scholar
PubMed
Search for other papers by Dagmar Führer in
Google Scholar
PubMed
Ana L. Maia
Ana L. Maia
Serviço de Endocrinologia, Hospital de Clínicas de Porto Alegre, Porto Alegre
Search for other papers by Ana L. Maia in
Google Scholar
PubMed
Search for other papers by Ana L. Maia in
Google Scholar
PubMed
Laura D. Locati
Laura D. Locati
Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan
Search for other papers by Laura D. Locati in
Google Scholar
PubMed
Search for other papers by Laura D. Locati in
Google Scholar
PubMed
Léa Maciel
Léa Maciel
Hospital das Clínicas de Ribeirăo Preto, Ribeirăo Preto, Brazil
Search for other papers by Léa Maciel in
Google Scholar
PubMed
Search for other papers by Léa Maciel in
Google Scholar
PubMed
Yi Wu
Yi Wu
Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
Search for other papers by Yi Wu in
Google Scholar
PubMed
Search for other papers by Yi Wu in
Google Scholar
PubMed
Kevin N. Heller
Kevin N. Heller
AstraZeneca, Gaithersburg, Md., USA
Search for other papers by Kevin N. Heller in
Google Scholar
PubMed
Search for other papers by Kevin N. Heller in
Google Scholar
PubMed
Alan Webster
Alan Webster
AstraZeneca, Macclesfield, UK
Search for other papers by Alan Webster in
Google Scholar
PubMed
Search for other papers by Alan Webster in
Google Scholar
PubMed
Rossella Elisei
Rossella Elisei
Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Introduction Medullary thyroid cancer (MTC) is a malignancy of the parafollicular C cells of the thyroid gland, and it accounts for an estimated 4% of thyroid cancers [ 1 , 2 ]. MTC can only be cured by surgery and, until recently, the
Luciana Puleo
Luciana Puleo
Endocrine Unit, Department of Clinical and Experimental Medicine
Search for other papers by Luciana Puleo in
Google Scholar
PubMed
Search for other papers by Luciana Puleo in
Google Scholar
PubMed
Laura Agate
Laura Agate
Endocrine Unit, Department of Clinical and Experimental Medicine
Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Laura Agate in
Google Scholar
PubMed
Irene Bargellini
Irene Bargellini
Department of Vascular and Interventional Radiology
Search for other papers by Irene Bargellini in
Google Scholar
PubMed
Search for other papers by Irene Bargellini in
Google Scholar
PubMed
Giuseppe Boni
Giuseppe Boni
Regional Center of Nuclear Medicine
Search for other papers by Giuseppe Boni in
Google Scholar
PubMed
Search for other papers by Giuseppe Boni in
Google Scholar
PubMed
Paolo Piaggi
Paolo Piaggi
Endocrine Unit, Department of Clinical and Experimental Medicine
Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Claudio Traino
Claudio Traino
Regional Center of Nuclear Medicine
Search for other papers by Claudio Traino in
Google Scholar
PubMed
Search for other papers by Claudio Traino in
Google Scholar
PubMed
Tommaso Depalo
Tommaso Depalo
Regional Center of Nuclear Medicine
Search for other papers by Tommaso Depalo in
Google Scholar
PubMed
Search for other papers by Tommaso Depalo in
Google Scholar
PubMed
Giulia Lorenzoni
Giulia Lorenzoni
Department of Vascular and Interventional Radiology
Search for other papers by Giulia Lorenzoni in
Google Scholar
PubMed
Search for other papers by Giulia Lorenzoni in
Google Scholar
PubMed
Francesca Bianchi
Francesca Bianchi
Regional Center of Nuclear Medicine
Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Duccio Volterrani
Duccio Volterrani
Regional Center of Nuclear Medicine
Search for other papers by Duccio Volterrani in
Google Scholar
PubMed
Search for other papers by Duccio Volterrani in
Google Scholar
PubMed
Sandra Brogioni
Sandra Brogioni
Endocrine Unit, Department of Clinical and Experimental Medicine
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Valeria Bottici
Valeria Bottici
Endocrine Unit, Department of Clinical and Experimental Medicine
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Maurizia Rossana Brunetto
Maurizia Rossana Brunetto
Hepatology Unit, University of Pisa, Pisa, Italy
Search for other papers by Maurizia Rossana Brunetto in
Google Scholar
PubMed
Search for other papers by Maurizia Rossana Brunetto in
Google Scholar
PubMed
Barbara Coco
Barbara Coco
Hepatology Unit, University of Pisa, Pisa, Italy
Search for other papers by Barbara Coco in
Google Scholar
PubMed
Search for other papers by Barbara Coco in
Google Scholar
PubMed
Eleonora Molinaro
Eleonora Molinaro
Endocrine Unit, Department of Clinical and Experimental Medicine
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Rossella Elisei
Rossella Elisei
Endocrine Unit, Department of Clinical and Experimental Medicine
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Introduction Medullary thyroid cancer (MTC) is a neuroendocrine tumor arising from parafollicular or calcitonin-producing C cells that retain the biochemical and pathological features of the cells from which it derives. MTC accounts for 3
Grace Segall
Grace Segall
Eli Lilly and Company, Indianapolis, IN, USA
Search for other papers by Grace Segall in
Google Scholar
PubMed
Search for other papers by Grace Segall in
Google Scholar
PubMed
Ravinder Singh
Ravinder Singh
Eli Lilly and Company, Indianapolis, IN, USA
Search for other papers by Ravinder Singh in
Google Scholar
PubMed
Search for other papers by Ravinder Singh in
Google Scholar
PubMed
Min-Hua Jen
Min-Hua Jen
Eli Lilly and Company, Indianapolis, IN, USA
Search for other papers by Min-Hua Jen in
Google Scholar
PubMed
Search for other papers by Min-Hua Jen in
Google Scholar
PubMed
Isaac Sanderson
Isaac Sanderson
Adelphi Real World, Bollington, UK
Search for other papers by Isaac Sanderson in
Google Scholar
PubMed
Search for other papers by Isaac Sanderson in
Google Scholar
PubMed
Alex Rider
Alex Rider
Adelphi Real World, Bollington, UK
Search for other papers by Alex Rider in
Google Scholar
PubMed
Search for other papers by Alex Rider in
Google Scholar
PubMed
Katie Lewis
Katie Lewis
Adelphi Real World, Bollington, UK
Search for other papers by Katie Lewis in
Google Scholar
PubMed
Search for other papers by Katie Lewis in
Google Scholar
PubMed
Urpo Kiiskinen
Urpo Kiiskinen
Eli Lilly and Company, Indianapolis, IN, USA
Search for other papers by Urpo Kiiskinen in
Google Scholar
PubMed
Search for other papers by Urpo Kiiskinen in
Google Scholar
PubMed
Introduction Medullary thyroid cancer (MTC) is a rare neuroendocrine tumour derived from calcitonin-secreting parafollicular C cells ( 1 ) and accounts for approximately 2‒4% of thyroid cancers ( 2 , 3 , 4 , 5 ) but up to 15% of thyroid-cancer
Cléber P. Camacho
Cléber P. Camacho
Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Search for other papers by Cléber P. Camacho in
Google Scholar
PubMed
Search for other papers by Cléber P. Camacho in
Google Scholar
PubMed
Susan C. Lindsey
Susan C. Lindsey
Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Search for other papers by Susan C. Lindsey in
Google Scholar
PubMed
Search for other papers by Susan C. Lindsey in
Google Scholar
PubMed
Teresa S. Kasamatsu
Teresa S. Kasamatsu
Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Search for other papers by Teresa S. Kasamatsu in
Google Scholar
PubMed
Search for other papers by Teresa S. Kasamatsu in
Google Scholar
PubMed
Alberto L. Machado
Alberto L. Machado
Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Alberto L. Machado in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Alberto L. Machado in
Google Scholar
PubMed
João Roberto M. Martins
João Roberto M. Martins
Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Search for other papers by João Roberto M. Martins in
Google Scholar
PubMed
Search for other papers by João Roberto M. Martins in
Google Scholar
PubMed
Rosa Paula M. Biscolla
Rosa Paula M. Biscolla
Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rosa Paula M. Biscolla in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rosa Paula M. Biscolla in
Google Scholar
PubMed
Magnus R. Dias da Silva
Magnus R. Dias da Silva
Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Search for other papers by Magnus R. Dias da Silva in
Google Scholar
PubMed
Search for other papers by Magnus R. Dias da Silva in
Google Scholar
PubMed
José Gilberto H. Vieira
José Gilberto H. Vieira
Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by José Gilberto H. Vieira in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by José Gilberto H. Vieira in
Google Scholar
PubMed
Rui M.B. Maciel
Rui M.B. Maciel
Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
Introduction Serum calcitonin (sCT) is a useful biomarker for medullary thyroid cancer (MTC) and is employed for its diagnosis and follow-up monitoring [ 1 ]. In addition, some guidelines advocate sCT measurements for the differential
